RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
EUR 15.2
(-4.4%)
EUR 15.2
(-4.4%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.73 Billion EUR | 15.66% |
| 2022 | 1.44 Billion EUR | 3.14% |
| 2021 | 1.4 Billion EUR | 3.08% |
| 2020 | 1.36 Billion EUR | 4.31% |
| 2019 | 1.3 Billion EUR | 5.76% |
| 2018 | 1.23 Billion EUR | 1.8% |
| 2017 | 1.21 Billion EUR | 2.95% |
| 2016 | 1.17 Billion EUR | 6.15% |
| 2015 | 1.1 Billion EUR | -26.64% |
| 2014 | 1.51 Billion EUR | -49.88% |
| 2013 | 3.01 Billion EUR | 5.2% |
| 2012 | 2.86 Billion EUR | 8.97% |
| 2011 | 2.62 Billion EUR | 3.09% |
| 2010 | 2.55 Billion EUR | 9.93% |
| 2009 | 2.32 Billion EUR | 8.91% |
| 2008 | 2.13 Billion EUR | 5.21% |
| 2007 | 2.02 Billion EUR | 4.74% |
| 2006 | 1.93 Billion EUR | 36.53% |
| 2005 | 1.41 Billion EUR | 35.51% |
| 2004 | 1.04 Billion EUR | 9.25% |
| 2003 | 956.26 Million EUR | 8.73% |
| 2002 | 879.49 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 392.69 Million EUR | 2.58% |
| 2024 Q1 | 382.81 Million EUR | 2.08% |
| 2023 Q4 | 375.02 Million EUR | 3.94% |
| 2023 Q1 | 361.5 Million EUR | -4.58% |
| 2023 Q3 | 360.79 Million EUR | -1.6% |
| 2023 FY | 1.67 Billion EUR | 15.66% |
| 2023 Q2 | 366.66 Million EUR | 1.43% |
| 2022 Q1 | 347.28 Million EUR | -6.51% |
| 2022 Q2 | 363.9 Million EUR | 4.78% |
| 2022 FY | 1.44 Billion EUR | 3.14% |
| 2022 Q3 | 356.06 Million EUR | -2.15% |
| 2022 Q4 | 378.83 Million EUR | 6.4% |
| 2021 Q2 | 346.89 Million EUR | 3.27% |
| 2021 Q3 | 347.74 Million EUR | 0.25% |
| 2021 Q4 | 371.45 Million EUR | 6.82% |
| 2021 Q1 | 335.9 Million EUR | -1.62% |
| 2021 FY | 1.4 Billion EUR | 3.08% |
| 2020 FY | 1.36 Billion EUR | 4.31% |
| 2020 Q3 | 348.17 Million EUR | 3.03% |
| 2020 Q4 | 341.44 Million EUR | -1.93% |
| 2020 Q2 | 337.92 Million EUR | 1.6% |
| 2020 Q1 | 332.61 Million EUR | -0.14% |
| 2019 Q1 | 324.21 Million EUR | 6.5% |
| 2019 FY | 1.3 Billion EUR | 5.76% |
| 2019 Q2 | 319.96 Million EUR | -1.31% |
| 2019 Q3 | 326.63 Million EUR | 2.08% |
| 2019 Q4 | 333.08 Million EUR | 1.98% |
| 2018 Q2 | 308.52 Million EUR | -1.0% |
| 2018 Q3 | 308.31 Million EUR | -0.07% |
| 2018 Q4 | 304.41 Million EUR | -1.27% |
| 2018 Q1 | 311.65 Million EUR | 0.98% |
| 2018 FY | 1.23 Billion EUR | 1.8% |
| 2017 Q3 | 304.01 Million EUR | 1.91% |
| 2017 FY | 1.21 Billion EUR | 2.95% |
| 2017 Q4 | 308.62 Million EUR | 1.52% |
| 2017 Q2 | 298.32 Million EUR | -0.6% |
| 2017 Q1 | 300.11 Million EUR | 3.12% |
| 2016 Q1 | 291.51 Million EUR | 5.54% |
| 2016 Q2 | 299.07 Million EUR | 2.59% |
| 2016 Q3 | 294.71 Million EUR | -1.46% |
| 2016 Q4 | 291.04 Million EUR | -1.24% |
| 2016 FY | 1.17 Billion EUR | 6.15% |
| 2015 Q2 | 279.26 Million EUR | 1.15% |
| 2015 Q1 | 276.09 Million EUR | 1.1% |
| 2015 FY | 1.1 Billion EUR | -26.64% |
| 2015 Q4 | 276.21 Million EUR | -0.14% |
| 2015 Q3 | 276.61 Million EUR | -0.95% |
| 2014 Q4 | 273.09 Million EUR | -1.88% |
| 2014 Q2 | 329.63 Million EUR | -47.63% |
| 2014 FY | 1.51 Billion EUR | -49.88% |
| 2014 Q3 | 278.31 Million EUR | -15.57% |
| 2014 Q1 | 629.48 Million EUR | -16.89% |
| 2013 Q3 | 749.56 Million EUR | -0.67% |
| 2013 Q4 | 757.43 Million EUR | 1.05% |
| 2013 FY | 3.01 Billion EUR | 5.2% |
| 2013 Q2 | 754.65 Million EUR | 0.33% |
| 2013 Q1 | 752.18 Million EUR | 1.32% |
| 2012 Q3 | 732.2 Million EUR | 3.41% |
| 2012 Q2 | 708.03 Million EUR | 3.78% |
| 2012 Q1 | 682.27 Million EUR | 1.71% |
| 2012 FY | 2.86 Billion EUR | 8.97% |
| 2012 Q4 | 742.4 Million EUR | 1.39% |
| 2011 Q2 | 651.08 Million EUR | 0.6% |
| 2011 Q1 | 647.21 Million EUR | 0.03% |
| 2011 Q3 | 660.02 Million EUR | 1.37% |
| 2011 Q4 | 670.82 Million EUR | 1.64% |
| 2011 FY | 2.62 Billion EUR | 3.09% |
| 2010 Q1 | 624.22 Million EUR | 4.57% |
| 2010 FY | 2.55 Billion EUR | 9.93% |
| 2010 Q4 | 647.02 Million EUR | 1.03% |
| 2010 Q3 | 640.44 Million EUR | 0.27% |
| 2010 Q2 | 638.69 Million EUR | 2.32% |
| 2009 FY | 2.32 Billion EUR | 8.91% |
| 2009 Q4 | 596.96 Million EUR | 2.46% |
| 2009 Q3 | 582.61 Million EUR | 0.21% |
| 2009 Q2 | 581.39 Million EUR | 3.98% |
| 2009 Q1 | 559.11 Million EUR | 0.0% |
| 2008 FY | 2.13 Billion EUR | 5.21% |
| 2007 FY | 2.02 Billion EUR | 4.74% |
| 2006 FY | 1.93 Billion EUR | 36.53% |
| 2005 FY | 1.41 Billion EUR | 35.51% |
| 2004 FY | 1.04 Billion EUR | 9.25% |
| 2003 FY | 956.26 Million EUR | 8.73% |
| 2002 FY | 879.49 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.45 Billion EUR | 91.083% |
| Fresenius SE & Co. KGaA | 22.29 Billion EUR | 92.221% |
| LIMES Schlosskliniken AG | 37.17 Million EUR | -4566.624% |
| M1 Kliniken AG | 316.31 Million EUR | -448.411% |
| Maternus-Kliniken Aktiengesellschaft | 102.3 Million EUR | -1595.624% |
| MEDICLIN Aktiengesellschaft | 761.59 Million EUR | -127.774% |
| VITA 34 AG | 77.06 Million EUR | -2151.077% |